Purchase Order HHSN269201500799P
- Not listed
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
- This federal contract was awarded by an unspecified government agency to Miltenyi Biotec, Inc., a global biotechnology company. The $44,402.00 contract is for the provision of laboratory equipment and supplies. It is not designated as a set-aside contract. Miltenyi Biotec specializes in scientific instruments, bioreagents, cell separation technology, flow cytometry platforms, and services supporting cell and gene therapy manufacturing. The company has served as a prime contractor on numerous...
- The federal contract award is for a service agreement with Miltenyi Biotec, Inc., a global biotechnology company that specializes in scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract, valued at $10,180.00, is a firm fixed-price purchase order awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the National Institutes of Health (NIH). The contract runs from August 1, 2024, to...
- This federal contract award was made by the Office of Logistics and Acquisition Operations, a civilian agency, to Miltenyi Biotec, Inc., a global biotechnology company, for the provision of analyzer maintenance services. The contract has a ceiling value of $84,186.00 and is a firm fixed price purchase order type. Miltenyi Biotec is an experienced federal contractor, having received numerous awards from agencies such as the National Institutes of Health (NIH), Department of Veterans Affairs (VA),...
- This federal contract award to Miltenyi Biotec, Inc. is for the supply of laboratory equipment, including flow cytometers, cell sorters, tissue dissociators, and associated reagents and consumables. The $4,881 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to...
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $5,550.00, is for the delivery and installation of specialized laboratory equipment and related reagents and consumables. This includes flow cytometers, cell sorters, tissue dissociators, and automated cell separation systems, as well as proprietary reagents and...
- This federal contract award from the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center was issued to Miltenyi Biotec, Inc., a global biotechnology company that provides products and services to support biomedical research and cell and gene therapy. The $1,090,887.29 Firm Fixed Price Delivery Order contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation...
- This $3,742.63 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract supports the delivery and installation of Miltenyi's proprietary CliniMACS cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated reagents and consumables. This award is a standalone...
This federal contract award, valued at $110,254.00, was issued by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Miltenyi Biotec, Inc., a global biotechnology company. The contract is for the delivery and installation of specialized laboratory equipment, reagents, and consumables used in cell isolation, analysis, and processing. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, including the National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense (DoD). This award is part of a larger $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, which provides for the supply of Miltenyi Biotec's proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027. The IDC ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation to support the center's cell processing and manufacturing capabilities for investigational cell therapy products used in clinical trials. The contract award did not use a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $0 | 9/16/15 | |
| Not listed | Not listed | $110.3k | 9/11/15 |